Evidence for affective reorganization following two suicide-focused interventions delivered during massed cognitive processing therapy for PTSD.

J Affect DisordMay 1, 2026 (epub)
Clinical ResearchPsychiatry

Craig J Bryan, Jeffrey V Tabares, Ennio Ammendola et al.

✦ AI-curated · Sources linked

In 30 seconds

This randomized controlled trial investigated the effects of crisis response planning (CRP) and safety planning (SP) on suicidal ideation in U.S. military personnel and veterans with PTSD. The study found that CRP improved affective regulation and altered the relationship between negative affect and suicidal ideation, promoting feedback loops that may reduce acute suicidal risk.

Key findings

  • CRP showed coupling between negative affect and positive affect, unlike SP, which coupled negative affect directly with suicidal ideation.
  • Suicidal ideation exhibited weak self-regulation, indicating greater persistence once elevated.
  • CRP strengthened affective regulation and integrated suicidal ideation with affective processes.

Why it matters

Understanding how interventions like CRP influence the dynamics of affect and suicidal ideation can inform treatment strategies for high-risk populations, potentially enhancing therapeutic outcomes and reducing suicide risk.

Source

PubMed · PMID 42070635

Published in J Affect Disord. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.